Atlas Trials

Cerebrospinal Fluid Biomarkers of Myotonic Dystrophy

Clinical trial NCT06075693 · RECRUITING

Trial details

NCT number
NCT06075693
Sponsor
Massachusetts General Hospital
Status
RECRUITING
Study type
OBSERVATIONAL
Myotonic Dystrophy Type 1
Start date
2022-08-01
Primary completion
2027-08-01
Enrollment
88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.